Name
OÜ Narva Sõltuvuste Ravikeskus
Registry code
11089279
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
11.01.2005 (19)
Financial year
01.01-31.12
Capital
3 068.00 €
Activity
86221 - Provision of specialised medical treatment
0 €
10 394 €
-
2 282 €
(estimate is approximate)
15 533 €
7
Submitted
No tax arrears
67%
21%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Juri Magerov 03.12.1963 (60) | 50% - 1 534.00 EUR | Board member | - | |
| Maria Ossipovski 25.01.1987 (37) | 50% - 1 534.00 EUR | Board member | - | |
| Tatjana Magerova 17.10.1965 (59) | - | - | - | Founder |
| 2019 18.05.2020 | 2020 26.06.2021 | 2021 28.06.2022 | 2022 13.06.2023 | 2023 27.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 0 € | 0 € | 1 557 € | 1 080 € | 0 € |
| Net profit (loss) for the period | 4 € | -135 € | -725 € | 1 068 € | 10 394 € |
| Profit Margin | - | - | -47% | 99% | - |
| Current Assets | 21 891 € | 27 619 € | 28 338 € | 28 463 € | 48 932 € |
| Fixed Assets | - | - | - | - | - |
| Total Assets | 21 891 € | 27 619 € | 28 338 € | 28 463 € | 48 932 € |
| Current Liabilities | 16 960 € | 22 823 € | 24 267 € | 23 324 € | 33 399 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 4 931 € | 4 796 € | 4 071 € | 5 139 € | 15 533 € |
| Employees | 8 | 8 | 8 | 7 | 7 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 23 119.11 € | 24 359.1 € | 11 |
| 2023 Q4 | - | 24 791.36 € | 26 108.52 € | 10 |
| 2023 Q3 | - | 22 815.27 € | 24 063.83 € | 11 |
| 2023 Q2 | - | 20 395.24 € | 21 511.33 € | 11 |
| 2023 Q1 | - | 19 745.02 € | 20 766.12 € | 11 |
| 2022 Q4 | - | 19 835.1 € | 20 901.72 € | 11 |
| 2022 Q3 | - | 19 860.62 € | 20 910.84 € | 11 |
| 2022 Q2 | - | 18 159.13 € | 19 231.37 € | 11 |
| 2022 Q1 | - | 17 280.13 € | 18 344.72 € | 11 |
| 2021 Q4 | - | 17 608.28 € | 18 744.96 € | 12 |
| 2021 Q3 | - | 17 904.91 € | 19 234.12 € | 12 |
| 2021 Q2 | - | 16 155.9 € | 17 379.43 € | 13 |
| 2021 Q1 | - | 16 313.12 € | 17 555.66 € | 12 |
| 2020 Q4 | - | 16 405.54 € | 17 762.7 € | 12 |
| 2020 Q3 | - | 16 317.3 € | 17 684.74 € | 12 |
| 2020 Q2 | - | 14 626.25 € | 15 872.82 € | 12 |
| 2020 Q1 | - | 14 759.79 € | 16 044.03 € | 12 |
